Mori Arkin Overview

  • Investor Type
  • Angel

  • Investments
  • 2

  • Portfolio
  • 2

Mori Arkin General Information


Mr. Mori Arkin serves as Chairman at Sol-Gel Technologies. He is the Founder & serves as Chairman at Arkin Communications. He serves as Board Member at Intera Oncology and Virility Medical. He Co-Founded and served as Partner at Sphera Funds Management. He is a Founder and Chairman at Arkin Holdings. He headed Agis, growing it into a leading dermatological company in the U.S., until its acquisition by Perrigo in 2005 for $818 million. He is also an Angel Investor. He also served as a Board member at SoniVe. He served as Board Member at Quiet Therapeutics and Endospan. He is also the Owner of Sol-Gel Technologies, a dermatology company. He holds a degree in psychology and philosophy from the Tel Aviv University.

Contact Information

Primary Investor Type
Angel (individual)
Primary Office
  • Herzliya
  • Israel

Mori Arkin Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Phytolon 16-Sep-2020 Early Stage VC 00.00 Food Products Generating Revenue
Butterfly Medical 29-Jan-2020 00000 00000 000 Therapeutic Devices Generating Revenue 0000 00000

Mori Arkin Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Mori Arkin Team (1)

Name Title Deals Funds Boards Office
Mori Arkin Angel Investor 00 0 0 Herzliya, Israel

Mori Arkin Co-Investors (16)

Name With Exits Lead Partner Series Industry
Arkin Holdings 1 Series chart Industry bar
Consensus Business Group 0 Series chart Industry bar
Eric Setton 0 0 Series chart Industry bar
Israel Innovation Authority 0 Series chart Industry bar
Trendlines 0 0 Series chart Industry bar